Proportion of isolates with resistance to ciprofloxacin reported to in Latvia
Latvia: Proportion of isolates with resistance to ciprofloxacin reported to was 60 in 2018. ◆ Volatile
Proportion of isolates with resistance to ciprofloxacin reported to in Latvia, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for proportion of isolates with resistance to ciprofloxacin reported to in Latvia is 60, measured in 2018. That is the highest value across all 10 years on record.
Compared with earlier readings it is up 140.0% on the previous year and up 440.0% over ten years.
Over the whole period, proportion of isolates with resistance to ciprofloxacin reported to in Latvia peaked at 60 in 2018 and was at its lowest, 10, in 2010.
Latvia ranks 26th of 54 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with resistance to ciprofloxacin reported to in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 11.11 | — |
| 2010 | 10 | -10.0% |
| 2011 | 28.57 | +185.7% |
| 2012 | 38.46 | +34.6% |
| 2013 | 26.32 | -31.6% |
| 2014 | 19.05 | -27.6% |
| 2015 | 11.11 | -41.7% |
| 2016 | 25 | +125.0% |
| 2017 | 25 | +0.0% |
| 2018 | 60 | +140.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 11.11 | 11.11 | 11.11 | 1 |
| 2010s | 27.06 | 10 | 60 | 9 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.02 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with resistance to ciprofloxacin reported to in Latvia?
- Proportion of isolates with resistance to ciprofloxacin reported to in Latvia was 60 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to ciprofloxacin reported to recorded in Latvia?
- The highest recorded value was 60 in 2018.
- What is the lowest proportion of isolates with resistance to ciprofloxacin reported to recorded in Latvia?
- The lowest recorded value was 10 in 2010.
- How does Latvia rank for proportion of isolates with resistance to ciprofloxacin reported to?
- Latvia ranks 26th out of 54 countries with data for 2018.
- Is proportion of isolates with resistance to ciprofloxacin reported to rising or falling in Latvia?
- Over the last ten years it is up 440.0%. The long-run trend across the full record is volatile.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).